We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
-8.31%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$9.35B
AUM Growth
+$1.57B
Cap. Flow
+$2.42B
Cap. Flow %
25.92%
Top 10 Hldgs %
31.61%
Holding
370
New
10
Increased
144
Reduced
147
Closed
31

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$109M
2
MSFT icon
Microsoft
MSFT
+$108M
3
CSCO icon
Cisco
CSCO
+$104M
4
NEE icon
NextEra Energy
NEE
+$102M
5
TXN icon
Texas Instruments
TXN
+$87.5M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$23M
2
VTR icon
Ventas
VTR
+$15.8M
3
PG icon
Procter & Gamble
PG
+$5.57M
4
ROP icon
Roper Technologies
ROP
+$4.51M
5
FAST icon
Fastenal
FAST
+$3.9M

Sector Composition

Rank Sector Weight
1 Technology 19.29%
2 Healthcare 18.06%
3 Financials 14.08%
4 Industrials 10.05%
5 Consumer Staples 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WELL icon
301
Welltower
WELL
$170B
$353K ﹤0.01%
5,081
CFR icon
302
Cullen/Frost Bankers
CFR
$10.2B
$352K ﹤0.01%
4,000
PRU icon
303
Prudential Financial
PRU
$41.9B
$351K ﹤0.01%
4,304
KSU
304
DELISTED
Kansas City Southern
KSU
$345K ﹤0.01%
3,613
-189
-5% -$19.2K
SCHW
305
Charles Schwab
SCHW
$187B
$341K ﹤0.01%
8,211
+2,025
+33% +$91.6K
EEM icon
306
iShares MSCI Emerging Markets ETF
EEM
$29.2B
$340K ﹤0.01%
8,701
-2,600
-23% -$104K
CHX
307
DELISTED
ChampionX
CHX
$335K ﹤0.01%
12,381
-5,154
-29% -$189K
MPC icon
308
Marathon Petroleum
MPC
$84B
$326K ﹤0.01%
5,517
+56
+1% +$3.82K
ATVI
309
DELISTED
Activision Blizzard
ATVI
$326K ﹤0.01%
6,995
AVY icon
310
Avery Dennison
AVY
$13.2B
$317K ﹤0.01%
3,530
+30
+0.9% +$2.82K
TEN
311
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$305K ﹤0.01%
11,139
-3,702
-25% -$124K
JCI icon
312
Johnson Controls International
JCI
$93.6B
$301K ﹤0.01%
10,148
-1,152
-10% -$38K
TGT icon
313
Target
TGT
$66.8B
$286K ﹤0.01%
4,324
-76
-2% -$5.85K
SU icon
314
Suncor Energy
SU
$71.8B
$277K ﹤0.01%
9,900
-6,060
-38% -$201K
BIIB icon
315
Biogen
BIIB
$30.5B
$269K ﹤0.01%
893
-32
-3% -$10.2K
EPD icon
316
Enterprise Products Partners
EPD
$82.3B
$258K ﹤0.01%
10,494
-100
-0.9% -$2.68K
BCE icon
317
BCE
BCE
$21.2B
$249K ﹤0.01%
6,309
-21,805
-78% -$893K
HEDJ icon
318
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.87B
$249K ﹤0.01%
8,838
-3,840
-30% -$114K
NNN icon
319
NNN REIT
NNN
$9.02B
$243K ﹤0.01%
5,000
FDX icon
320
FedEx
FDX
$74.7B
$241K ﹤0.01%
1,492
+46
+3% +$9.73K
HIW icon
321
Highwoods Properties
HIW
$3.47B
$240K ﹤0.01%
6,200
BIP icon
322
Brookfield Infrastructure Partners
BIP
$17.9B
$238K ﹤0.01%
11,592
YUM icon
323
Yum! Brands
YUM
$41.6B
$237K ﹤0.01%
2,577
OXY icon
324
Occidental Petroleum
OXY
$56B
$223K ﹤0.01%
3,634
ET icon
325
Energy Transfer Partners
ET
$71.2B
$221K ﹤0.01%
+16,720
New +$254K

Similar funds

Bahl & Gaynor's Q4 2018 Portfolio in Review

As of Q4 2018, Bahl & Gaynor held 370 positions worth $9.35B, up 20% from $7.78B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor deployed $2.42B of net new capital in Q4 2018, opening 10 new positions and adding to 144 existing holdings. Its largest new stake was Celanese: 21,191 shares worth $1.91M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ventas, an estimated $15.8M trimmed.

  • Bahl & Gaynor's largest Q4 2018 buy was Celanese: 21,191 shares worth $1.91M.
  • Bahl & Gaynor added most to JPMorgan Chase in Q4 2018, an estimated $109M increase.
  • Bahl & Gaynor's biggest Q4 2018 reduction was Ventas, cutting an estimated $15.8M.
  • Bahl & Gaynor fully exited Praxair Inc in Q4 2018, selling an estimated $23M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $9.35B portfolio in Q4 2018.
  • Bahl & Gaynor opened 10 new positions and closed 31 in Q4 2018.
  • Bahl & Gaynor's portfolio value rose 20% quarter-over-quarter to $9.35B.

Based on Bahl & Gaynor's 13F filing for Q4 2018, filed 12 Feb 2019.